Iron and hepatitis C: beginning to make sense

J Gastroenterol Hepatol. 2007 Nov;22(11):1703-4. doi: 10.1111/j.1440-1746.2007.05106.x.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Alcohol Drinking / adverse effects
  • Antiviral Agents / therapeutic use*
  • Disease Progression
  • Drug Resistance, Multiple, Viral*
  • Drug Therapy, Combination
  • Hepatitis C, Chronic / complications
  • Hepatitis C, Chronic / drug therapy*
  • Hepatitis C, Chronic / metabolism
  • Hepatitis C, Chronic / pathology
  • Hepatitis C, Chronic / therapy
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / therapeutic use*
  • Iron / metabolism*
  • Iron Overload / metabolism
  • Iron Overload / pathology
  • Iron Overload / therapy
  • Iron Overload / virology*
  • Liver / metabolism*
  • Liver / pathology
  • Liver / virology
  • Phlebotomy
  • Platelet Count
  • Recombinant Proteins
  • Ribavirin / therapeutic use*
  • Risk Factors
  • Severity of Illness Index
  • Sex Factors
  • Transaminases / blood
  • Treatment Failure
  • Treatment Outcome

Substances

  • Antiviral Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Ribavirin
  • Iron
  • Transaminases